Nurix Therapeutics (NasdaqGM:NRIX) 2025 Conference Transcript

Nurix Therapeutics (NasdaqGM:NRIX) 2025 Conference September 09, 2025 10:50 AM ET Company ParticipantsArthur Sands - President, CEO, and Board DirectorConference Call ParticipantsBrian Skorney - Senior Biotech AnalystBrian SkorneyMorning, everyone. Thank you for joining our next session. I'm Brian Skorney. I'm one of Baird's Senior Biotech Analysts. I'm very happy to have with us presenting Nurix. It's a company that I cover. I'm very excited about the working in the protein degradation space. They have a l ...